BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 9844455)

  • 1. [Malignant diffuse mesothelioma: contribution of 23 cases].
    Montero Martínez C; Yebra Pimentel MT; Bouso Montero M; Blanco Aparicio M; Veres Racaamonde A; Otero González I; Verea Hernando H
    Rev Clin Esp; 1998 Oct; 198(10):665-8. PubMed ID: 9844455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peculiar features of mesothelioma occurrence as related to exposure patterns and circumstances in the Lombard Region, Italy.
    Pesatori AC; Mensi C
    Med Lav; 2005; 96(4):354-9. PubMed ID: 16457432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent hydropneumothorax as a presenting feature of malignant mesothelioma.
    Guha K; Jones D; Hull JH; Ho TB
    Eur J Intern Med; 2008 Jan; 19(1):63-4. PubMed ID: 18206605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence of malignant mesothelioma (1980-1999) and asbestos exposure in 190 cases diagnosed among residents of the province of Brescia].
    Barbieri PG; Lombardi S; Candela A; Pezzotti C; Binda I
    Med Lav; 2001; 92(4):249-62. PubMed ID: 11676187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The incidence of malignant mesothelioma (1977-1996) and asbestos exposure in the population of an area neighboring Lake Iseo, northern Italy].
    Barbieri PG; Migliori M; Merler E
    Med Lav; 1999; 90(6):762-75. PubMed ID: 10703192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological analysis of lung cancer resembling malignant pleural mesothelioma.
    Kobashi Y; Matsushima T; Irei T
    Respirology; 2005 Nov; 10(5):660-5. PubMed ID: 16268922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimates of pleural mesothelioma incidence in the Lazio region (Italy), 1997-2000].
    Palange S; Ascoli V; Carnovale-Scalzo C; Forastiere F; D'Ippoliti D; Presti EL; Di Domenicantonio R; Pasetto R; Perucci CA
    Med Lav; 2004; 95(1):45-54. PubMed ID: 15112747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental exposure to asbestos and the exposure-response relationship with mesothelioma.
    Madkour MT; El Bokhary MS; Awad Allah HI; Awad AA; Mahmoud HF
    East Mediterr Health J; 2009; 15(1):25-38. PubMed ID: 19469424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and prognosis of malignant mesothelioma. A description of 8 clinical cases].
    Piffer S; Zeni G; Aldovini D; Polla E; Peterlongo P
    Minerva Med; 1989 Apr; 80(4):405-10. PubMed ID: 2725943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant pleural mesothelioma. Report of 19 cases.
    Shearin JC; Jackson D
    J Thorac Cardiovasc Surg; 1976 Apr; 71(4):621-7. PubMed ID: 1263545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Renal cell carcinoma with malignant pleural mesothelioma after asbestos exposure: a case report].
    Sawazaki H; Yoshikawa T; Takahashi T; Taki Y; Takeuchi H; Sakai Y
    Hinyokika Kiyo; 2007 Nov; 53(11):805-8. PubMed ID: 18051806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant malignant mesothelioma of the pleura, peritoneum, and tunica vaginalis testis.
    Ascoli V; Facciolo F; Rahimi S; Scalzo CC; Nardi F
    Diagn Cytopathol; 1996 May; 14(3):243-8. PubMed ID: 8732655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracranial metastases from malignant pleural mesothelioma. Report of three autopsy cases and review of the literature.
    Falconieri G; Grandi G; DiBonito L; Bonifacio-Gori D; Giarelli L
    Arch Pathol Lab Med; 1991 Jun; 115(6):591-5. PubMed ID: 1710103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and prognosis in malignant pleural mesothelioma: a prospective study.
    Mårtensson G; Hagmar B; Zettergren L
    Eur J Respir Dis; 1984 Apr; 65(3):169-78. PubMed ID: 6723826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Problematic cases of mesothelioma reported to the Dutch Institute for Asbestos Victims: evaluation by the Mesothelioma Working Group of the Netherlands Association of Pulmonologists and Specialists in Tuberculosis].
    Baas P; Sleeswijk P; Strankinga WF; van Hezik EJ; Burgers JA; Tan KY; Schouwink JH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(14):759-63. PubMed ID: 15835628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathohistological diagnosis and differential diagnosis.
    Tischoff I; Neid M; Neumann V; Tannapfel A
    Recent Results Cancer Res; 2011; 189():57-78. PubMed ID: 21479896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tuscany mesothelioma registry (1988-2000): evaluation of asbestos exposure].
    Gorini G; Silvestri S; Merler E; Chellini E; Cacciarini V; Seniori Costantini AS
    Med Lav; 2002; 93(6):507-18. PubMed ID: 12596421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant mesothelioma in Basse-Normandie, a French population study. Descriptive analysis, prognostic factors and survival].
    Desoubeaux N; Bouvier V; Gervais R; Galateau-Salle F; Thibon P; Leplumey T; Herbert C; Lecherbonnier Y; Daviet JP; Letourneux M
    Rev Epidemiol Sante Publique; 2001 Dec; 49(6):523-9. PubMed ID: 11845101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and course of 38 cases of malignant pleural mesothelioma observed in the Marseilles region].
    Irisson M; Velardocchio JM; Viallat JR; Boutin C
    Poumon Coeur; 1983; 39(1):5-11. PubMed ID: 6866894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of histological and immunohistochemical markers to distinguish pleural malignant mesothelioma and in situ mesothelioma from reactive mesothelial hyperplasia and reactive pleural fibrosis.
    Cury PM; Butcher DN; Corrin B; Nicholson AG
    J Pathol; 1999 Oct; 189(2):251-7. PubMed ID: 10547583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.